Home › Funds › EcoR1 Capital, LLC › ZYME
EcoR1 Capital, LLC position in ZYME
ZYMEWORKS INC · Health Care
EcoR1 Capital, LLC reported holding 22,970,388 shares of ZYME (ZYMEWORKS INC) in its Q3 2026 13F filing — a position valued at US$608.5M, representing 28.82% of its reported portfolio and ranking #1 among its reported holdings. EcoR1 Capital, LLC has disclosed ZYME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How EcoR1 Capital, LLC's ZYME position evolved
EcoR1 Capital, LLC first disclosed a stake in ZYME in Q3 2023 at 13,437,473 shares (US$85.2M). The position peaked in Q3 2026 at 22,970,388 shares, worth US$608.5M. Across 13 filings, EcoR1 Capital, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 22,970,388 shares valued at US$608.5M. Notable position changes include a 33% increase in Q2 2025 (shares rose 36% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 13.44M | $85.19M | New |
| Q4 2023 | 13.44M | $139.62M | Hold |
| Q1 2024 | 13.44M | $141.36M | Hold |
| Q2 2024 | 13.44M | $114.35M | Hold |
| Q3 2024 | 13.44M | $168.64M | Hold |
| Q4 2024 | 15.03M | $220.01M | Add |
| Q1 2025 | 17.26M | $205.56M | Add |
| Q2 2025 | 22.97M | $288.28M | Add |
| Q3 2025 | 22.97M | $392.33M | Hold |
| Q4 2025 | 22.97M | $604.81M | Hold |
| Q1 2026 | 22.97M | $575.18M | Hold |
| Q2 2026 | 22.97M | $600.45M | Hold |
| Q3 2026 | 22.97M | $608.49M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZYME and 13F data
ZYME (ZYMEWORKS INC) is a Health Care company. 25 other funds we track also report a position in ZYME — the largest reported positions include Rubric Capital Management LP (US$183.0M), PERCEPTIVE ADVISORS LLC (US$109.3M), BVF INC/IL (US$95.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZYME
- Rubric Capital Management LP 7.00M sh · $182.98M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.18M sh · $109.34M · Q2 2026
- BVF INC/IL 3.65M sh · $95.39M · Q2 2026
- Nextech Invest Ltd. 1.11M sh · $29.12M · Q2 2026
- Prosight Management, LP 721.10K sh · $19.10M · Q3 2026
- Redmile Group, LLC 491.65K sh · $12.85M · Q2 2026
More on EcoR1 Capital, LLC
FAQ
How long has EcoR1 Capital, LLC held ZYME?
EcoR1 Capital, LLC has disclosed ZYME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is EcoR1 Capital, LLC's current position in ZYME?
As of Q3 2026, EcoR1 Capital, LLC holds 22.97M shares of ZYME (ZYMEWORKS INC), valued at $608.49M, representing 28.82% of its reported portfolio and ranking #1.
Has EcoR1 Capital, LLC been buying or selling ZYME?
In the latest 13F filing (Q3 2026), EcoR1 Capital, LLC held unchanged its position in ZYME. The position peaked in Q3 2026 at 22.97M shares.
Which other funds hold ZYME?
Other major institutional holders of ZYME include Rubric Capital Management LP, PERCEPTIVE ADVISORS LLC, BVF INC/IL, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.